Fortitude Advisory Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Sell
9,700
-469
-5% -$12.3K 0.09% 200
2026
Q1
$286K Sell
10,169
-937
-8% -$24.9K 0.13% 157
2025
Q4
$277K Sell
11,106
-381
-3% -$9.61K 0.12% 151
2025
Q3
$293K Sell
11,487
-1,804
-14% -$44.5K 0.16% 142
2025
Q2
$322K Sell
13,291
-56
-0.4% -$1.31K 0.18% 119
2025
Q1
$294K Sell
13,347
-2,531
-16% -$66.2K 0.21% 113
2024
Q4
$421K Sell
15,878
-1,523
-9% -$41.3K 0.25% 81
2024
Q3
$504K Buy
17,401
+1,746
+11% +$50.9K 0.32% 71
2024
Q2
$438K Sell
15,655
-3,370
-18% -$92.8K 0.26% 75
2024
Q1
$528K Sell
19,025
-480
-2% -$13.3K 0.3% 76
2023
Q4
$562K Buy
19,505
+156
+0.8% +$4.72K 0.34% 61
2023
Q3
$642K Buy
19,349
+3,607
+23% +$128K 0.43% 46
2023
Q2
$577K Sell
15,742
-548
-3% -$21.3K 0.42% 50
2023
Q1
$665K Sell
16,290
-1,408
-8% -$60.8K 0.52% 47
2022
Q4
$907K Buy
17,698
+48
+0.3% +$2.3K 0.77% 23
2022
Q3
$772K Buy
17,650
+231
+1% +$11.2K 0.73% 29
2022
Q2
$913K Sell
17,419
-326
-2% -$16.6K 0.83% 22
2022
Q1
$919K Sell
17,745
-2,117
-11% -$110K 0.49% 31
2021
Q4
$1.17M Buy
+19,862
New +$984K 0.59% 23

Other funds holding PFE

Fortitude Advisory Group's PFE Position: Q2 2026 in Review

Fortitude Advisory Group reduced its Pfizer (PFE) stake by 4.6% in Q2 2026, selling an estimated $12.3K and leaving 9,700 shares worth $234K. The position accounts for 0.09% of the portfolio, ranked #200.

Fortitude Advisory Group first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.17M in Q4 2021. 1,132 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fortitude Advisory Group held 9,700 shares of Pfizer worth $234K as of Q2 2026.
  • Fortitude Advisory Group sold 469 Pfizer shares in Q2 2026, an estimated $12.3K.
  • Pfizer made up 0.09% of Fortitude Advisory Group's portfolio in Q2 2026, its #200 holding.
  • Fortitude Advisory Group first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Fortitude Advisory Group's Pfizer position peaked at $1.17M in Q4 2021.
  • 1,132 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fortitude Advisory Group's 13F filing for Q2 2026, filed 22 Jul 2026.